» Articles » PMID: 21677425

Altered Phenotype of Blood Dendritic Cells in Patients with Acute Pneumonia

Overview
Journal Respiration
Publisher Karger
Specialty Pulmonary Medicine
Date 2011 Jun 17
PMID 21677425
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dendritic cells (DCs) play a key role in the host defence against inhaled pathogens. However, the phenotype of blood DCs in patients with acute respiratory infections is unknown.

Objective: To investigate the number and the expression of function-associated molecules of blood DCs in patients with acute infectious pneumonia.

Methods: Sixteen patients with acute pneumonia and 19 controls without pneumonia were included in the study. The number as well as the expression of function-associated molecules of myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) were analysed in peripheral blood using four-colour flow cytometry.

Results: Elevated concentrations of procalcitonin (median: 0.55 ng/ml) and the rapid response to antibiotic treatment suggested a bacterial origin of the pneumonia in the patients. Total mDC (median: 27% of the controls) and pDC counts (median: 53% of the controls) were markedly reduced in patients with pneumonia, as compared to the controls. Percentages of blood mDCs, but not pDCs, were negatively correlated with serum concentrations of C-reactive protein. Patients with pneumonia were characterised by a significantly increased expression of Fc gamma receptors (CD32 and CD64) on mDCs and the Toll-like receptor 9 (TLR9) on pDCs.

Conclusions: Circulating DCs are markedly reduced in patients with pneumonia, and characterised by an up-regulation of molecules recognising pathogen-associated molecular patterns and opsonised antigens.

Citing Articles

Immunoadjuvant therapy in the regulation of cell death in sepsis: recent advances and future directions.

Islam M, Watanabe E, Salma U, Ozaki M, Irahara T, Tanabe S Front Immunol. 2024; 15:1493214.

PMID: 39720718 PMC: 11666431. DOI: 10.3389/fimmu.2024.1493214.


The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review.

Lazzaro A, De Girolamo G, Filippi V, Innocenti G, Santinelli L, Ceccarelli G Int J Mol Sci. 2022; 23(2).

PMID: 35054993 PMC: 8776148. DOI: 10.3390/ijms23020803.


Immune Intervention in Sepsis.

Chen J, Wei H Front Pharmacol. 2021; 12:718089.

PMID: 34335278 PMC: 8317843. DOI: 10.3389/fphar.2021.718089.


Role of cellular events in the pathophysiology of sepsis.

Bhan C, Dipankar P, Chakraborty P, Sarangi P Inflamm Res. 2016; 65(11):853-868.

PMID: 27392441 DOI: 10.1007/s00011-016-0970-x.


Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Hotchkiss R, Monneret G, Payen D Nat Rev Immunol. 2013; 13(12):862-74.

PMID: 24232462 PMC: 4077177. DOI: 10.1038/nri3552.